Differentiated Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial [Phase 1]
Phase 1 feasibility trial evaluating repurposed drugs for thyroid carcinoma; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
An ongoing prospective, non-interventional post-authorization safety study for patients with unresectable differentiated thyroid carcinoma t…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial [NA]
A ClinicalTrials.gov update for the Thrive Track trial aimed at managing emotional support for young adults with thyroid cancer, melanoma, a…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer [Phase 2]
This update describes a Phase 2 trial evaluating encorafenib and binimetinib, with or without nivolumab, for metastatic radioiodine-refracto…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of cabozantinib (XL184) and nivolumab in patients with various advanced cancers …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer [Phase 3]
A Phase 3 clinical trial comparing a targeted therapy with chemotherapy in patients with refractory differentiated thyroid carcinoma is curr…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Adjuvant Radiotherapy in High Risk Locally Advanced DTC [Phase 3]
A Phase 3 clinical trial evaluating adjuvant radiotherapy for high-risk locally advanced differentiated thyroid carcinoma is currently recru…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer [NA]
A clinical trial update indicates recruitment for a study of Sacituzumab Govitecan in combination with immunotherapy for advanced thyroid ca…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer [Phase 2]
This update describes a Phase 2 clinical trial (COACH) comparing two methods to suppress thyrotropin in patients with advanced differentiate…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma [Phase 3]
A Phase 3 trial comparing AL2846 capsules to placebo in advanced radioiodine-refractory differentiated thyroid carcinoma is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial of ST-1898 for locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma is currently re…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update indicating that XL092 for locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer …
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Sinibolimab in combination with Lenvatinib as neoadjuvant therapy for locally advanced unresectable differ…
-
FDA approval · 2024-11-26FDA Approved: SORAFENIB — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for sorafenib submitted by Dr. Reddy's Laboratories Inc. This action provides supplemental approval …
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib [Phase 2]
Phase 2 clinical trial update investigating Anlotinib for differentiated thyroid carcinoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Comparison of Quality of Life in Patients with Differentiated Thyroid Carcinoma Undergoing Different Surgery
This clinical trial update examines quality of life outcomes in patients with differentiated thyroid carcinoma undergoing different surgical…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Spanish Study for Molecular Characterization of Thyroid Carcinoma
A Spanish study conducted by Grupo Español de Tratamiento de Tumores de Cabeza y Cuello is pursuing molecular characterization of thyroid ca…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
A completed clinical trial update reporting the clinical and surgical outcomes of pediatric and adolescent differentiated thyroid carcinoma,…
-
FDA approval · 2024-06-12FDA Approved: RETEVMO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for RETEVMO (selpercatinib) from Eli Lilly and Company.
-
CLINICAL_TRIALS safety_alert · 2024-05-29Clinical Trial Update: Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
This post-marketing surveillance update assesses the safety of Cabometyx in Korean patients with Renal Cell Carcinoma, Hepatocellular Carcin…
-
FDA approval · 2024-03-05FDA Approved: SORAFENIB TOSYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA granted a supplemental approval for sorafenib tosylate (generic sorafenib) by Mylan Pharmaceuticals Inc., allowing the generic product t…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…